BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression

por Tancredi, Alessandro, Gusyatiner, Olga, Bady, Pierre, Buri, Michelle C., Lomazzi, Rémy, Chiesi, Davide, Messerer, Mahmoud, Hegi, Monika E.
Publicado 2022

Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells

por Beltzig, Lea, Schwarzenbach, Christian, Leukel, Petra, Frauenknecht, Katrin B. M., Sommer, Clemens, Tancredi, Alessandro, Hegi, Monika E., Christmann, Markus, Kaina, Bernd
Publicado 2022